Bikam Pharmaceuticals
AcquiredCambridge, United States · Founded 2007 · $11.0M raised
- Headquarters
- Cambridge
- Employees
- 11–50
- Founded
- 2007
- Business Model
- B2B
- Total Funding
- $11.0M
- Last Round
- $11.0M Series AJan 2020
- Rounds
- 1
- Acquisition Date
- Jul 2014
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Bikam Pharmaceuticals was a biopharmaceutical company that discovered and developed small-molecule pharmacological chaperones for misfolded proteins in the retina, targeting degenerative eye diseases including retinitis pigmentosa and dry age-related macular degeneration. Its lead compound was an orally active chaperone that bound misfolded rod opsin, correcting its trafficking to the photoreceptor cell surface and outer segment. Shire acquired Bikam in July 2014 for $2.5M upfront plus up to $92M in milestone payments.
Summary
Bikam Pharmaceuticals is a Biotech company based in Cambridge, United States, founded in 2007. It has raised $11.0M in total across 1 round, most recently a $11.0M Series A round in Jan 2020. Investors include CHL Medical Partners, HealthCare and F-Prime Capital.
Funding & Exit History
2020 (est.)
Sign up to see all 2 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bikam-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/bikam-pharmaceuticals" alt="Bikam Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>